Wound Management Technologies, Inc. (WMT) is engaged in developing and marketing products for the advanced wound care market, as pursued through the Company�s wholly owned subsidiary, Wound Care Innovations, LLC (WCI), which brings a mix of products and procedures to the wound care arena. The patented collagen fragments (CRX) of CellerateRX are a fraction of the size of the native collagen molecules and particles found in other products. CellerateRX is cleared by the food and drug administration (FDA) as a medical device for use on all acute and chronic wounds, except third degree burns, and is ready for distribution in both gel and powder form. Manufacturing of the Company's products is conducted by Applied Nutritionals, LLC (Applied Nutritionals), which owns the CellerateRX trademark. During the year ended December 31, 2011, its warehousing, shipping, and physical inventory management were outsourced to Pac-Source, LLC of Roches. On December 29, 2011, WMT sold Secure eHealth, LLC.